What Diffusion Tensor Imaging (DTI) Markers Are in ADHD?

PostedOctober 6, 2025

UpdatedOctober 6, 2025

ByMy Patient Advice

Author: Phoebe Carter, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Recent studies have uncovered distinct ADHD DTI markers that shed light on how the brain’s white matter may differ in individuals with the condition. These neuroimaging biomarkers give insight into how connectivity and communication between brain regions are affected, offering a more detailed understanding of ADHD beyond traditional behavioural assessments.

The most consistent marker identified is fractional anisotropy (FA), which measures the directionality of water diffusion in white matter tracts. In ADHD, FA values are often reduced in key pathways such as the corpus callosum, superior longitudinal fasciculus, and frontostriatal circuits. These reductions suggest white matter integrity loss, affecting processes like attention, planning, and emotional regulation.

Symptoms Linked to DTI Markers & Treatment Paths

Below are common symptoms associated with these DTI changes, and how treatment may help address them:

Impulsivity and Poor Planning

Disrupted connections in frontal white matter tracts can lead to impulsive behaviour and difficulty organising tasks or keeping routines. Medication (especially stimulants) may help by improving neural signalling and supporting better connectivity, while CBT offers structured strategies for planning, self‑monitoring, and decision making.

Emotional Dysregulation

Altered connectivity in tracts linked to limbic regions may contribute to mood swings, irritability, or sensitivity to stress. A combination of behavioural therapy and medication can help stabilise mood and build strategies for managing emotional responses.

Visit providers like ADHD Certify for personal consultations that stay abreast of the latest brain imaging research.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to ADHD DTI markers.

Phoebe Carter, MSc

Author

Phoebe Carter is a clinical psychologist with a Master’s in Clinical Psychology and a Bachelor’s in Applied Psychology. She has experience working with both children and adults, conducting psychological assessments, developing individualized treatment plans, and delivering evidence-based therapies. Phoebe specialises in neurodevelopmental conditions such as autism spectrum disorder (ASD), ADHD, and learning disabilities, as well as mood, anxiety, psychotic, and personality disorders. She is skilled in CBT, behaviour modification, ABA, and motivational interviewing, and is dedicated to providing compassionate, evidence-based mental health care to individuals of all ages.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.